Microembolism and catheter ablation II: Effects of cerebral microemboli injection in a canine model

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 1, 2013, Pages 23-30

  Haines, David E ^a   Stewart, Mark T ^b   Barka, Noah D ^b   Kirchhof, Nicole ^b   Lentz, Linnea R ^b   Reinking, Nicki M ^b   Urban, Jon F ^b   Halimi, Franck ^c   Deneke, Thomas ^d   Kanal, Emanuel ^e  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b MEDTRONIC INC   (United States)

^c Centre Medico Chirugical   (France)

^d Heart Center Bad Neustadt   (Germany)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Ablation; Atrial fibrillation; Complications; Embolism; MRI

Indexed keywords

CONTRAST MEDIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BRAIN EMBOLISM; CATHETER ABLATION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DOG; HISTOPATHOLOGY; INTERNAL CAROTID ARTERY; MICROBUBBLE; MICROEMBOLISM; NEUROPATHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; VERTEBRAL ARTERY; AIR EMBOLISM; ANIMAL; ANIMAL BEHAVIOR; BRAIN ANGIOGRAPHY; CATHETERIZATION; DISEASE MODEL; EQUIPMENT DESIGN; HEART CATHETER; INSTRUMENTATION; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

ANIMALS; BEHAVIOR, ANIMAL; CARDIAC CATHETERS; CAROTID ARTERY, INTERNAL; CATHETER ABLATION; CATHETERIZATION, PERIPHERAL; CEREBRAL ANGIOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; DOGS; EMBOLISM, AIR; EQUIPMENT DESIGN; INTRACRANIAL EMBOLISM; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; TIME FACTORS; VERTEBRAL ARTERY;

MLCS; MLOWN;

EID: 84876302381     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.973461     Document Type: Article

References (29)

1. Gaita F, Leclercq JF, Schumacher B, Scaglione M, Toso E, Halimi F, Schade A, Froehner S, Ziegler V, Sergi D, Cesarani F, Blandino A. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol. 2011;22:961-968.
2. Herrera Siklódy C, Deneke T, Hocini M, Lehrmann H, Shin DI, Miyazaki S, Henschke S, Fluegel P, Schiebeling-Römer J, Bansmann PM, Bourdias T, Dousset V, Haïssaguerre M, Arentz T. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58:681-688.
3. Deneke T, Shin DI, Balta O, Bünz K, Fassbender F, Mügge A, Anders H, Horlitz M, Päsler M, Karthikapallil S, Arentz T, Beyer D, Bansmann M. Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm. 2011;8:1705-1711.
4. Neumann T, Kuniss M, Conradi G, Janin S, Berkowitsch A, Wojcik M, Rixe J, Erkapic D, Zaltsberg S, Rolf A, Bachmann G, Dill T, Hamm CW, Pitschner HF. MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace. 2011;13:37-44.
5. Rillig A, Meyerfeldt U, Tilz RR, Talazko J, Arya A, Zvereva V, Birkemeyer R, Miljak T, Hajredini B, Wohlmuth P, Fink U, Jung W. Incidence and long-term follow-up of silent cerebral lesions after pulmonary vein isolation using a remote robotic navigation system as compared with manual ablation. Circ Arrhythm Electrophysiol. 2012;5:15-21.
6. Derdeyn CP. Diffusion-weighted imaging as a surrogate marker for stroke as a complication of cerebrovascular procedures and devices. AJNR Am J Neuroradiol. 2001;22:1234-1235.
7. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
8. Crawley F, Stygall J, Lunn S, Harrison M, Brown MM, Newman S. Comparison of microembolism detected by transcranial Doppler and neuropsychological sequelae of carotid surgery and percutaneous transluminal angioplasty. Stroke. 2000;31:1329-1334.
9. Haines DE, Stewart MT, Ahlberg S, Barka ND, Condie C, Fiedler GR, Kirchhof NA, Halimi F, Deneke T. Microembolism and catheter ablation I: a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia. Circ Arrhythm Electrophysiol. 2013;6:16-22.
10. Kruis RW, Vlasveld FA, Van Dijk D. The (un)importance of cerebral microemboli. Semin Cardiothorac Vasc Anesth. 2010;14:111-118.
11. Rodriguez RA, Rubens FD, Wozny D, Nathan HJ. Cerebral emboli detected by transcranial Doppler during cardiopulmonary bypass are not correlated with postoperative cognitive deficits. Stroke. 2010;41:2229-2235.
12. Wolf O, Heider P, Heinz M, Poppert H, Schmidt-Thieme T, Sander D, Gräfin von Einsiedel H, Brandl R. Frequency, clinical significance and course of cerebral ischemic events after carotid endarterectomy evaluated by serial diffusion weighted imaging. Eur J Vasc Endovasc Surg. 2004;27:167-171.
13. Altinbas A, van Zandvoort MJ, van den Berg E, Jongen LM, Algra A, Moll FL, Nederkoorn PJ, Mali WP, Bonati LH, Brown MM, Kappelle LJ, van der Worp HB. Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology. 2011;77:1084-1090.
14. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28.
15. Kilicaslan F, Verma A, Saad E, Rossillo A, Davis DA, Prasad SK, Wazni O, Marrouche NF, Raber LN, Cummings JE, Beheiry S, Hao S, Burkhardt JD, Saliba W, Schweikert RA, Martin DO, Natale A. Transcranial Doppler detection of microembolic signals during pulmonary vein antrum isolation: implications for titration of radiofrequency energy. J Cardiovasc Electrophysiol. 2006;17:495-501.
16. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A, Balta O, Schrickel J, Bitzen A, Lüderitz B, Sommer T. Cerebral diffusionweighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol. 2006;17:1-7.
17. Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F, Boffano C, Gandini G, Valentini MC, De Ponti R, Halimi F, Leclercq JF. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122:1667-1673.
18. Schrickel JW, Lickfett L, Lewalter T, Mittman-Braun E, Selbach S, Strach K, Nähle CP, Schwab JO, Linhart M, Andrié R, Nickenig G, Sommer T. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace. 2010;12:52-57.
19. Schwarz N, Kuniss M, Nedelmann M, Kaps M, Bachmann G, Neumann T, Pitschner HF, Gerriets T. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm. 2010;7:1761-1767.
20. Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Stroke. 2011;42:1251-1254.
21. Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke. 2008;39:2765-2768.
22. Schaefer PW, Hunter GJ, He J, Hamberg LM, Sorensen AG, Schwamm LH, Koroshetz WJ, Gonzalez RG. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol. 2002;23:1785-1794.
23. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, Saver JL. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174-1180.
24. Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, Kidwell CS, Mohr JP, Sloan M, Sorensen AG, Warach S; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;75:177-185.
25. Bonati LH, Lyrer PA, Wetzel SG, Steck AJ, Engelter ST. Diffusion weighted imaging, apparent diffusion coefficient maps and stroke etiology. J Neurol. 2005;252:1387-1393.
26. Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33: 1267-1273.
27. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke. 2006;37:98-104.
28. Bonati LH, Kessel-Schaefer A, Linka AZ, Buser P, Wetzel SG, Radhue EW, Lyrer PA, Engelter ST. Diffusion-weighted imaging in stroke attributable to patent foramen ovale. Stroke. 2006;37:2030-2034.
29. Nagura J, Suzuki K, Johnston SC, Nagata K, Kuriyama N, Ozasa K, Watanabe Y, Nakajima K. Diffusion-weighted MRI in evaluation of transient ischemic attack. J Stroke Cerebrovasc Dis. 2003;12:137-142.